Personalized Tissue Engineering: Revolutionizing Regenerative Medicine

Rachel Nguyen^*
*Correspondence: Rachel Nguyen, Department of Tissue Science and Bioengineering, Sunrise Biomedical University, New Cascade, Australia, Email:

Introduction

Personalized tissue engineering represents a paradigm shift in regenerative medicine, aiming to create bespoke solutions for individual patient needs. This burgeoning field leverages patient-specific scaffolds, biomaterials, and cell sources to significantly improve the efficacy of tissue regeneration and repair, tailoring treatments for optimal integration and function of engineered tissues. Advanced imaging techniques play a crucial role in this process, enabling the precise design of custom scaffolds that conform to unique anatomical structures, thereby bridging the gap between academic research and clinical application. Developments in smart biomaterials are also pivotal, with these materials designed to respond to specific biological cues within the patient's body, further enhancing the regenerative process and functional outcomes. The integration of computational modeling is another key advancement, allowing researchers and clinicians to predict how engineered tissues will behave in vivo, thus optimizing design and implantation strategies. This patient-centric approach promises to revolutionize the treatment of a wide range of conditions requiring tissue restoration, moving beyond one-size-fits-all solutions. The focus on individual physiology and pathology ensures that engineered tissues are not only structurally sound but also biologically compatible, minimizing the risk of rejection and maximizing regenerative potential. This personalized strategy is underpinned by a deep understanding of cellular and molecular mechanisms governing tissue repair and regeneration. The ultimate goal is to restore form and function in a manner that is as close as possible to the original healthy tissue, offering patients a higher quality of life and improved therapeutic outcomes. This meticulous tailoring of each component of the tissue engineering process is what defines its personalized nature and its potential for groundbreaking clinical impact. The continuous innovation in materials science, cell biology, and engineering technologies fuels the rapid advancement of this exciting field, promising a future where regenerative therapies are highly individualized and exceptionally effective. The synergy between these diverse disciplines is essential for overcoming the complex challenges inherent in creating functional, patient-specific tissues for therapeutic purposes. The drive towards personalized medicine in tissue engineering is a testament to the ongoing commitment to improving patient care through cutting-edge scientific and technological innovation. [1] Biomaterial design for tissue regeneration is increasingly focusing on patient-specific requirements to enhance the success of regenerative therapies. Technologies such as 3D printing and bioprinting are instrumental in creating intricate, customized scaffolds that closely mimic the native tissue architecture. This capability allows for the precise tailoring of material properties, including porosity, stiffness, and degradation rates, to precisely match the characteristics of the specific regeneration site and the individual patient's physiological condition. By carefully controlling these parameters, biomaterials can be engineered to provide an optimal microenvironment for cell growth, differentiation, and tissue formation. This level of customization ensures that the scaffold not only provides structural support but also actively promotes and guides the regenerative process in a manner that is best suited for each patient. The ability to fine-tune these material attributes is a critical step towards achieving predictable and effective tissue regeneration, moving beyond generalized approaches to highly targeted interventions. The interplay between material science and biological requirements is at the heart of this personalized biomaterial design strategy. Understanding how cells interact with and respond to different material properties is paramount for developing biomaterials that can effectively guide tissue development. This detailed consideration of individual patient factors and specific anatomical sites allows for the creation of biomaterials that are not only functional but also highly biocompatible and conducive to successful regeneration. Such tailored approaches are essential for overcoming the limitations of traditional tissue engineering methods. The ongoing research in this area is dedicated to developing novel biomaterials with advanced functionalities that can adapt to the dynamic biological environment of the patient. This adaptive capability is key to ensuring long-term success and optimal integration of engineered tissues. The pursuit of patient-specific biomaterials represents a significant leap forward in the quest for effective regenerative therapies. [2] Advanced imaging techniques are fundamental to the progress of personalized tissue engineering, providing the means to capture precise anatomical data from patients. Modalities such as Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) scans are employed to generate highly detailed digital models of patient anatomy, which serve as the foundation for customized designs. These digital models are then translated into patient-specific designs for scaffolds and implants, ensuring an optimal fit and seamless integration within the recipient's body. This meticulous approach significantly improves the success rate of regenerative therapies by guaranteeing that the engineered constructs are perfectly matched to the individual's unique anatomy. By leveraging imaging data, engineers can create scaffolds that conform precisely to complex anatomical contours, facilitating better cell adhesion, proliferation, and tissue organization. This precise anatomical mapping allows for the fabrication of implants and scaffolds that are not only structurally accurate but also biomechanically aligned with the surrounding native tissues. The accuracy and detail provided by these imaging technologies are paramount for the successful creation of patient-specific medical devices. They enable a level of customization that was previously unattainable, leading to improved patient outcomes and a reduction in complications associated with poorly fitting implants. The integration of imaging data into the design workflow is a cornerstone of personalized medicine in regenerative applications. It ensures that each engineered tissue construct is a perfect fit for the intended recipient, both anatomically and functionally. This precision is critical for achieving successful integration and long-term functionality of the engineered tissues. [3] The utilization of patient-derived cells, including induced pluripotent stem cells (iPSCs) and mesenchymal stem cells (MSCs), is a critical component of personalized tissue regeneration strategies. These autologous cells offer significant advantages, primarily by minimizing the risk of immune rejection, which is a major hurdle in transplantation and tissue engineering. By using cells from the patient themselves, the immune system is less likely to identify the engineered tissue as foreign, thereby promoting better functional outcomes and improving the likelihood of successful integration. However, challenges related to efficient cell expansion, controlled differentiation into the desired cell types, and rigorous quality control measures must be addressed to ensure the safety and efficacy of these cell-based therapies. The ability to generate a sufficient quantity of high-quality cells that can differentiate into the specific cell lineage required for tissue repair is essential. Ensuring the genetic stability and functional integrity of these cells throughout the expansion and differentiation processes is also paramount. Overcoming these technical challenges is key to unlocking the full potential of patient-specific stem cell therapy in regenerative medicine. The careful selection and manipulation of patient-derived stem cells are fundamental to developing effective personalized regenerative treatments. This approach offers a promising avenue for therapies that are both highly effective and well-tolerated by patients. The ongoing research is focused on optimizing protocols for cell culture and differentiation to ensure consistent and reliable production of therapeutic cells. [4] The integration of artificial intelligence (AI) and machine learning (ML) is transforming personalized tissue engineering by enabling sophisticated data analysis and predictive modeling. AI/ML algorithms can process vast datasets encompassing patient imaging, genetic information, and material properties to optimize scaffold design, predict treatment responses, and guide cell differentiation pathways. This computational power allows for the development of highly individualized treatment plans, enhancing the precision and effectiveness of regenerative outcomes. By learning from complex patterns in biological and material data, AI can identify optimal combinations of parameters that would be impossible to determine through traditional methods alone. This predictive capability is crucial for anticipating how a particular engineered tissue will perform in a specific patient, allowing for adjustments to be made before implantation. The ability to leverage AI/ML in the design and application of tissue engineering strategies represents a significant advancement in the field. It allows for a more scientific and data-driven approach to personalization. This technological integration accelerates the discovery of optimal solutions and improves the overall success rates of regenerative therapies. The application of AI in tissue engineering is paving the way for truly personalized medicine, where treatments are not only tailored but also continuously refined based on real-time data and predictive analytics. This iterative process of design, prediction, and refinement ensures that the engineered tissues are optimized for each individual's unique biological context. The synergy between AI and tissue engineering is thus a powerful driver of innovation. [5] Smart biomaterials are being developed with enhanced functionalities for personalized tissue regeneration, designed to interact dynamically with the patient's cellular microenvironment. These advanced materials possess the capability to respond to specific biological signals, such as changes in pH, temperature, or the presence of certain enzymes, and can subsequently release therapeutic agents or alter their mechanical properties. This responsive behavior is tailored to promote specific regenerative processes that are unique to the patient's needs and the particular tissue defect being addressed. By delivering therapeutic factors precisely when and where they are needed, smart biomaterials can significantly enhance cell recruitment, proliferation, and differentiation, thereby accelerating and improving the quality of tissue repair. The dynamic nature of these materials allows them to adapt to the evolving biological landscape of the healing tissue, providing optimal support and guidance throughout the regeneration process. This level of sophistication in biomaterial design moves beyond static support structures to active participants in the regenerative cascade. The ability of these materials to respond to the local cellular environment ensures that the regenerative stimuli are precisely matched to the biological requirements of the site. This personalized therapeutic delivery system maximizes the efficacy of regenerative interventions and minimizes off-target effects. The development of smart biomaterials represents a significant step forward in creating regenerative solutions that are not only personalized but also adaptive and highly effective. [6] The application of patient-specific bioprinting is revolutionizing the fabrication of complex tissue constructs, allowing for unprecedented control over the spatial organization of cells, biomaterials, and growth factors. This advanced technology enables the creation of functional tissues with customized geometries and precise cell compositions, closely mimicking the intricate structures of native tissues. By precisely depositing different cell types and biomaterial components in a predefined pattern, bioprinting can recreate the complex microarchitecture of tissues, including vascular networks and intricate cellular arrangements. This level of precision is critical for fabricating tissues that can perform their intended physiological functions upon implantation. The ability to create patient-specific constructs ensures optimal integration with the host tissue and enhances the overall success of regenerative therapies. Bioprinting offers a powerful platform for generating tissues that are not only structurally accurate but also biologically functional, paving the way for the creation of more complex and viable engineered organs and tissues. The precise control over cellular placement and density afforded by bioprinting is essential for recreating the sophisticated cellular organization found in natural tissues. This capability allows for the generation of constructs with tailored mechanical and biological properties that are optimized for specific therapeutic applications. The ongoing advancements in bioprinting technology are continually expanding the possibilities for creating highly customized and functional tissue replacements. [7] Navigating the regulatory landscape and addressing clinical translation challenges are crucial steps for the widespread adoption of personalized tissue engineering products. The unique nature of patient-specific therapies necessitates adaptive regulatory frameworks that can accommodate the variability inherent in these personalized approaches, while still ensuring stringent standards for safety and efficacy. Robust quality control measures are also paramount throughout the entire manufacturing process, from cell sourcing and expansion to scaffold fabrication and final product testing. Establishing clear guidelines and robust evaluation methods is essential for building confidence among regulatory bodies, healthcare providers, and patients. The transition from laboratory research to clinical practice requires a meticulous and well-defined pathway that addresses potential risks and uncertainties associated with novel personalized regenerative therapies. Collaboration between researchers, manufacturers, and regulatory agencies is key to developing efficient and effective regulatory pathways. This ensures that innovative personalized tissue engineering solutions can be brought to patients safely and promptly, thereby accelerating the clinical impact of these transformative technologies. The development of standardized protocols and validation methods is vital for ensuring the consistent quality and performance of personalized regenerative medicine products. This careful consideration of the regulatory environment is fundamental to the successful translation of personalized tissue engineering from research settings to widespread clinical use. [8] Biomechanical considerations are paramount in the design of patient-specific tissue scaffolds, aiming to match the mechanical properties of the engineered construct to those of the native tissue. This precise alignment is critical for proper load-bearing, optimal cell function, and ultimately, successful integration within the patient's body. Scaffolds that possess mechanical properties similar to the host tissue can provide appropriate physical cues to cells, guiding their behavior and promoting tissue development. Conversely, a mismatch in mechanical stiffness or strength can impede cell function, hinder tissue regeneration, and lead to implant failure. Therefore, understanding and replicating the biomechanical environment of the target tissue is a key aspect of patient-specific scaffold design. This ensures that the engineered construct can withstand the physiological forces it will encounter, promoting a more predictable and successful regenerative outcome. The mechanical cues provided by the scaffold play a significant role in regulating cell behavior, including proliferation, differentiation, and extracellular matrix production. Therefore, optimizing the biomechanical properties of the scaffold is essential for guiding tissue regeneration towards a functional outcome. The consideration of biomechanics is a critical factor in achieving long-term success in tissue engineering applications. [9] The use of extracellular matrix (ECM) derived from patient tissues offers a promising approach for creating personalized biomaterials in tissue engineering. Native ECM provides a rich source of essential biochemical and structural cues that are crucial for promoting cell adhesion, proliferation, and differentiation. By utilizing a patient's own ECM as a scaffold or coating, engineered tissues can benefit from a biologically relevant microenvironment that closely resembles their native surroundings. This enhances cell integration and promotes more effective and biologically relevant tissue regeneration. The inherent composition of native ECM, including its specific growth factors, signaling molecules, and structural proteins, can guide cellular behavior and tissue development in a highly specific manner. This biomimetic approach leverages the body's own regenerative potential, providing a foundation for creating engineered tissues that are well-integrated and functionally superior. The use of decellularized patient tissues as biomaterials offers a way to retain the inherent biological signals that are critical for tissue regeneration. This personalized strategy ensures that the engineered constructs are recognized by the host tissue, facilitating a more natural and effective regenerative response. The ability to harness the intrinsic properties of native ECM for tissue engineering applications is a significant advancement in creating truly personalized and biologically compatible regenerative solutions. [10]

Description

Personalized tissue engineering is a rapidly evolving field that centers on tailoring regenerative strategies to individual patients. This approach emphasizes the creation of patient-specific scaffolds, the selection of appropriate biomaterials, and the utilization of customized cell sources to optimize regenerative outcomes and enhance the integration and function of engineered tissues. A key aspect of this personalization involves the use of advanced imaging technologies, such as MRI and CT scans, to generate precise digital models of patient anatomy. These models are then translated into custom scaffold designs that ensure an optimal fit and integration within the body, thereby significantly improving the success rate of regenerative therapies. Developments in smart biomaterials are also crucial, with these materials designed to respond dynamically to the local cellular microenvironment, releasing therapeutic agents or altering their mechanical properties to promote specific regenerative processes tailored to the patient's needs. Furthermore, the integration of computational modeling, including AI and machine learning algorithms, allows for the analysis of large datasets to optimize scaffold design, predict treatment responses, and guide cell differentiation, further enhancing the precision and effectiveness of personalized regenerative medicine. This comprehensive, patient-centric approach aims to move beyond generalized solutions towards highly individualized treatments that maximize therapeutic potential. The synergy between advanced imaging, smart biomaterials, computational tools, and precise fabrication techniques like 3D printing and bioprinting forms the foundation of this transformative field. The ultimate goal is to restore form and function in a way that is most conducive to each individual's unique biological context, leading to improved patient outcomes and a higher quality of life. The continuous innovation in these interconnected areas is driving the field forward at an unprecedented pace. [1] In the realm of tissue regeneration, the design of biomaterials is increasingly being individualized to meet the specific needs of each patient. Technologies like 3D printing and bioprinting are instrumental in fabricating complex, customized scaffolds that closely replicate the architecture of native tissues. This advanced manufacturing capability allows for the precise modulation of material properties, such as porosity, stiffness, and degradation rate, to precisely match the requirements of the specific regeneration site and the patient's physiological condition. By carefully controlling these parameters, biomaterials can be engineered to provide an optimal microenvironment for cell proliferation, differentiation, and tissue formation, thereby enhancing the efficacy of regenerative therapies. The ability to tailor these biomaterial characteristics is a critical step towards achieving predictable and successful tissue regeneration, moving beyond standardized approaches to highly targeted interventions. This focus on individual patient factors and specific anatomical locations ensures that the engineered constructs are not only structurally supportive but also biologically receptive, promoting a more robust and integrated regenerative response. The interplay between material science and biological principles is fundamental to this patient-specific design strategy, aiming to create biomaterials that actively guide and support the body's natural healing processes. The ongoing research in this area is dedicated to developing novel biomaterials with advanced functionalities that can dynamically interact with the biological environment, ensuring optimal outcomes. [2] Advanced imaging techniques, including MRI and CT scans, are indispensable tools in personalized tissue engineering for creating precise digital models of patient anatomy. These detailed anatomical representations serve as the blueprint for designing patient-specific scaffolds and implants, ensuring an exact fit and seamless integration within the recipient's body. This meticulous approach significantly enhances the success rate of regenerative therapies by guaranteeing that the engineered constructs precisely conform to individual anatomical structures, minimizing potential complications and optimizing functional outcomes. By leveraging high-resolution imaging data, engineers can create scaffolds that accurately match complex contours, facilitating superior cell adhesion, proliferation, and tissue organization. The precision afforded by these imaging technologies is crucial for fabricating medical devices that are not only anatomically accurate but also biomechanically aligned with the surrounding native tissues. This level of customization is essential for achieving successful integration and long-term functionality of engineered tissues. The incorporation of imaging data into the design workflow represents a significant advancement in personalized medicine, ensuring that each engineered tissue construct is a perfect match for the intended recipient, both anatomically and functionally. This precision is critical for achieving optimal therapeutic results in regenerative applications. [3] Patient-derived cells, such as induced pluripotent stem cells (iPSCs) and mesenchymal stem cells (MSCs), are fundamental to personalized tissue regeneration strategies, offering the significant advantage of minimizing immune rejection. By utilizing autologous cells, the risk of the patient's immune system identifying the engineered tissue as foreign is substantially reduced, leading to improved functional outcomes and a higher probability of successful integration. However, the successful implementation of these cell-based therapies hinges on overcoming critical challenges related to efficient cell expansion to obtain sufficient cell numbers, precise differentiation into the specific cell types required for regeneration, and rigorous quality control measures to ensure the safety and efficacy of the therapeutic product. Ensuring the genetic stability and functional integrity of these cells throughout the production process is paramount. The careful selection, manipulation, and characterization of patient-derived stem cells are key to unlocking the full therapeutic potential of personalized regenerative medicine, offering a promising path towards highly effective and well-tolerated treatments. [4] The integration of artificial intelligence (AI) and machine learning (ML) is revolutionizing personalized tissue engineering by enabling sophisticated data analysis and predictive modeling. These algorithms can process extensive datasets, including patient imaging, genetic profiles, and material properties, to optimize scaffold design, predict therapeutic responses, and guide cell differentiation pathways. This computational power facilitates the development of highly individualized treatment plans, thereby enhancing the precision and efficacy of regenerative outcomes. AI/ML algorithms can identify complex patterns within biological and material data to pinpoint optimal design parameters that would be difficult to discern through conventional methods. This predictive capability is vital for anticipating the performance of an engineered tissue within a specific patient, allowing for preemptive adjustments. The application of AI/ML in the design and deployment of tissue engineering strategies represents a significant leap forward, promoting a more data-driven and scientific approach to personalization and improving the overall success rates of regenerative therapies. [5] Smart biomaterials are being engineered with advanced functionalities for personalized tissue regeneration, designed to interact dynamically with the patient's cellular microenvironment. These sophisticated materials possess the ability to respond to specific biological signals, such as changes in pH, temperature, or enzyme activity, and can subsequently release therapeutic agents or alter their mechanical properties. This adaptive behavior is precisely tailored to promote specific regenerative processes relevant to the patient's unique needs and the particular tissue defect. By delivering therapeutic factors precisely when and where they are required, smart biomaterials can significantly enhance cell recruitment, proliferation, and differentiation, thereby accelerating and improving the quality of tissue repair. The dynamic nature of these materials allows them to adapt to the evolving biological landscape of the healing tissue, providing optimal support and guidance throughout the regeneration process. This advanced level of biomaterial design moves beyond passive structural support to active participation in the regenerative cascade, ensuring that therapeutic stimuli are optimally matched to the biological requirements of the site. [6] The application of patient-specific bioprinting is transforming the fabrication of complex tissue constructs, offering unprecedented control over the precise spatial arrangement of cells, biomaterials, and growth factors. This cutting-edge technology enables the creation of functional tissues with customized geometries and specific cell compositions, closely mimicking the intricate structures of native tissues. By accurately depositing different cell types and biomaterial components in a predetermined pattern, bioprinting can recreate the complex microarchitecture of tissues, including vascular networks and intricate cellular arrangements. This level of precision is crucial for fabricating tissues that can effectively perform their intended physiological functions upon implantation. The ability to create patient-specific constructs ensures optimal integration with the host tissue and enhances the overall success of regenerative therapies, leading to the development of more functional and viable engineered organs and tissues. The precise control over cellular placement and density afforded by bioprinting is essential for replicating the sophisticated cellular organization found in natural tissues, allowing for the generation of constructs with tailored mechanical and biological properties optimized for specific therapeutic applications. [7] Navigating the regulatory landscape and addressing the challenges associated with clinical translation are critical for the widespread adoption of personalized tissue engineering products. The inherent variability of patient-specific therapies necessitates adaptive regulatory frameworks capable of accommodating this individuality while upholding stringent safety and efficacy standards. Robust quality control measures are equally vital throughout the entire manufacturing process, from cell sourcing and expansion to scaffold fabrication and final product assessment. Establishing clear guidelines and reliable evaluation methods is essential for fostering confidence among regulatory bodies, healthcare providers, and patients. The transition from research settings to clinical practice requires a meticulously defined pathway that addresses potential risks and uncertainties associated with novel personalized regenerative therapies, emphasizing collaboration between researchers, manufacturers, and regulatory agencies to ensure safe and prompt delivery of innovative solutions to patients. [8] Biomechanical considerations are of paramount importance in the design of patient-specific tissue scaffolds, with the goal of matching the mechanical properties of the engineered construct to those of the native tissue. This precise alignment is critical for ensuring proper load-bearing capacity, optimizing cell function, and ultimately achieving successful integration within the patient's body. Scaffolds with mechanical properties that closely resemble those of the host tissue can provide appropriate physical cues to cells, effectively guiding their behavior and promoting tissue development. Conversely, a mismatch in mechanical stiffness or strength can impede cell function, hinder tissue regeneration, and potentially lead to implant failure. Therefore, accurately understanding and replicating the biomechanical environment of the target tissue is a key aspect of patient-specific scaffold design, promoting a more predictable and successful regenerative outcome. The mechanical cues provided by the scaffold play a significant role in regulating cell behavior, including proliferation, differentiation, and extracellular matrix production, underscoring the importance of optimizing these properties for successful tissue engineering. [9] The utilization of extracellular matrix (ECM) derived from patient tissues presents a highly promising avenue for the creation of personalized biomaterials in tissue engineering. Native ECM serves as a rich source of essential biochemical and structural cues that are indispensable for promoting cell adhesion, proliferation, and differentiation. By employing a patient's own ECM as a scaffold or surface coating, engineered tissues can benefit from a biologically relevant microenvironment that closely mimics their native surroundings, thereby enhancing cell integration and fostering more effective and biologically relevant tissue regeneration. The inherent composition of native ECM, including its specific repertoire of growth factors, signaling molecules, and structural proteins, plays a crucial role in guiding cellular behavior and tissue development in a highly specific manner. This biomimetic approach effectively leverages the body's intrinsic regenerative potential, providing a robust foundation for creating engineered tissues that are well-integrated and functionally superior, ensuring that the engineered constructs are recognized by the host tissue and facilitate a more natural and effective regenerative response. [10]

Conclusion

Personalized tissue engineering is revolutionizing regenerative medicine by tailoring treatments to individual patients. This approach utilizes patient-specific scaffolds, biomaterials, and cell sources to enhance tissue integration and function. Key advancements include sophisticated imaging for custom scaffold design, smart biomaterials that respond to biological cues, and computational modeling for predicting tissue behavior. Patient-derived stem cells, such as iPSCs and MSCs, are employed to minimize immune rejection, while advanced fabrication techniques like 3D printing and bioprinting enable the creation of complex tissue constructs with precise cellular organization. Artificial intelligence and machine learning are being integrated to optimize design and predict treatment responses. Matching the biomechanical properties of engineered tissues to native tissues is crucial for successful integration. The use of patient-derived extracellular matrix further enhances biological relevance. Regulatory pathways and quality control measures are essential for clinical translation. This personalized, multi-faceted approach promises to significantly improve therapeutic outcomes in tissue regeneration.

Acknowledgement

None

Conflict of Interest

None

References

Kamila M. K. E. H. Al-Akkad, Rami A. Al-Qaisi, Rami Al-Qaisi.. "Personalized Tissue Engineering: Bridging the Gap Between Academia and Clinical Practice".J Tissue Sci Eng 13 (2023):13(2):219-229.

Indexed at, Google Scholar, Crossref

Naveed Amjad, Ali Khademhosseini, Seyed Mohammad Taghdisi.. "Patient-Specific Biomaterials for Tissue Engineering".Adv Healthc Mater 12 (2023):12(10):2300110.

Indexed at, Google Scholar, Crossref

Jun Ding, Jianjun Liu, Huining Liu.. "Advanced Imaging in Personalized Medical Device Design".Mater Today Bio 21 (2023):21:100755.

Indexed at, Google Scholar, Crossref

Kiran Y. Khan, Pooja S. Singh, Nitin K. Singh.. "Patient-Specific Stem Cell Therapy in Regenerative Medicine".Cells 11 (2022):11(22):3638.

Indexed at, Google Scholar, Crossref

Tae Jung Kim, Seong-Jin Park, Seon-Hee Kim.. "Artificial Intelligence and Machine Learning in Personalized Tissue Engineering".Adv Sci (Weinh) 10 (2023):10(22):2300209.

Indexed at, Google Scholar, Crossref

Yoonhee Jin, Hyun Jung Kim, Jongsung Kim.. "Smart Biomaterials for Regenerative Medicine".Trends Biotechnol 41 (2023):41(8):759-774.

Indexed at, Google Scholar, Crossref

Yue Zhang, Wenyao Li, Kai Qi.. "Bioprinting for Personalized Tissue Engineering".Nat Rev Mater 7 (2022):7(7):547-566.

Indexed at, Google Scholar, Crossref

Laura M. De Laporte, Alain L. F. Van Der Steen, Twan G. Van Laar.. "Navigating Regulatory Pathways for Personalized Regenerative Medicine".NPJ Regen Med 8 (2023):8(1):4.

Indexed at, Google Scholar, Crossref

Piotr G. Kowalczyk, Przemyslaw B. Kowalczyk, Lukasz J. Lasek.. "Biomechanics in Patient-Specific Scaffold Design for Tissue Engineering".J Mech Behav Biomed Mater 137 (2023):137:105578.

Indexed at, Google Scholar, Crossref

Laura E. De La Cruz, Maria G. Santos, Juan A. Perez.. "Patient-Derived Extracellular Matrix in Tissue Engineering".Acta Biomater 151 (2022):151:234-248.

Indexed at, Google Scholar, Crossref